AEON Biopharma, Inc. (AEON) stock
AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.12+0.01 (+9.61%)
Close on Nov 18, 2026Market cap $6.20MP/E –Yield –
AEON Biopharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
AEON Biopharma's free cash flow for the twelve months ending Dec 31, 2025 was -$17.31M. For fiscal 2025 it was -$17.31M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.31M | – |
| FY2022 | Dec 31, 2022 | -$35.89M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$4.71M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.60M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.91M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.46M | – |
See a number that looks wrong?